Framework · Contracts Finder
Oncotype DX Breast Cancer Testing
Groups 1 related procurement, worth £272.7k combined.
- 1
- Member contracts
- £272.7k
- Combined value
- 1
- Buyers
Oncotype DX Breast Cancer Testing is a UK public-sector framework or programme that groups 1 related procurement worth £272.7k combined. The member contracts and call-offs below are run by 1 participating buyer.
Details
- Source
- Contracts Finder
- Member contracts
- 1
- Combined value
- £272,700
- First activity
- 3 Mar 2026
- Latest activity
- 3 Mar 2026
- Participating buyers
- 1
Member procurements
Contracts and call-offs grouped under this framework.
| Procurement | Buyer | Stage | Value |
|---|---|---|---|
| Oncotype DX Breast Cancer Testing | East Sussex Healthcare NHS Trust | Award | £272.7k |
Participating buyers
FAQs about this framework
What is the "Oncotype DX Breast Cancer Testing" framework?
It groups 1 related UK public procurement worth £272,700 combined, published via Contracts Finder.
Which buyers use this framework?
1 buyer participate, including East Sussex Healthcare NHS Trust.
When is this framework active?
Recorded activity runs from 3 Mar 2026 to 3 Mar 2026.
Get ahead on framework opportunities
Enable tracks frameworks and their call-offs across UK public procurement so you can position before the next mini-competition. Talk to us.
Get in touch with Enable